Aquestive CEO Daniel Barber Sells 25,000 Shares

What Happened
Daniel Barber, President, CEO and a director of Aquestive Therapeutics (AQST), sold 25,000 shares in an open-market/private sale on September 15, 2026. The reported weighted-average price was $4.8195 per share (range $4.78–$4.90), producing gross proceeds of about $120,487. This was a sale (not a purchase or grant), which is commonly routine insider selling.

Key Details

• Transaction date: 2026-09-15; Form 4 filed: 2026-09-16 (appears timely).
• Shares sold: 25,000; weighted-average price: $4.8195; proceeds ≈ $120,487.
• Price range disclosed (footnote): $4.78 to $4.90 per share; Barber offers to provide a per-price breakdown on request (Footnote F1).
• Transaction type reported as "S" (sale) — described as "open market or private sale" in the filing.
• Shares owned after the transaction: not specified in the summary provided here — see the full Form 4 for total holdings and percent ownership.
• No 10b5-1 plan, option exercise, gift, or tax-withholding note was indicated in the provided details.

Context
Insider sales do not necessarily signal negative judgment about the company; executives sell for many reasons (diversification, taxes, liquidity). Purchases are typically more informative about insider confidence, but routine sales like this are common and should be weighed with other signals and company fundamentals. For the exact per-price breakdown or full holding details, consult the linked SEC Form 4 (Accession 0001214659-26-011731).